NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 1.170
-0.030 (-2.50%)
Last updated: Oct 23, 2026, 8:01 AM CEST
NovaBridge Biosciences Employees
NovaBridge Biosciences had 30 employees as of December 31, 2025. The number of employees decreased by 2 or 6.25% compared to the previous year.
Employees
30
Change (1Y)
-2
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
141.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30 | -2 | -6.25% |
| Dec 31, 2024 | 32 | -188 | -85.45% |
| Dec 31, 2023 | 220 | -158 | -41.80% |
| Dec 31, 2021 | 378 | 150 | 65.79% |
| Dec 31, 2020 | 228 | 43 | 23.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Bayer Aktiengesellschaft | 87,830 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| MEDICLIN Aktiengesellschaft | 7,048 |
| Stratec SE | 1,383 |
| Medios AG | 989 |
| LIMES Schlosskliniken AG | 314 |
NovaBridge Biosciences News
- 19 hours ago - NovaBridge announces presentation of results from Phase 1b study of givastomig - TheFly
- 1 day ago - NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development - GlobeNewsWire
- 6 days ago - Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia - GlobeNewsWire
- 13 days ago - Wuhan Hiteck enters exclusive license agreement with Visara - TheFly
- 13 days ago - Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China - PRNewsWire
- 13 days ago - Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis - GlobeNewsWire
- 17 days ago - NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026 - GlobeNewsWire
- 6 weeks ago - NovaBridge Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts